Trials / Unknown
UnknownNCT05085093
Protective Efficacy of HPV Vaccination After Treatment of HPV Related Diseases
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 414 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- —
Summary
To understand the HPV infection status and subtype distribution of patients, and to study the protective effect of prophylactic HPV vaccination on the recurrence of HPV related diseases after treatment through a prospective cohort study. To provide data support for the primary prevention of HPV related diseases in Chinese women after treatment, and to analyze the related factors of HPV related disease recurrence and HPV continuous positive.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HPV vaccine | Patients choose to be vaccinated or not to be vaccinated with HPV vaccine according to their own wishes |
Timeline
- Start date
- 2021-09-18
- Primary completion
- 2022-03-01
- Completion
- 2024-09-01
- First posted
- 2021-10-20
- Last updated
- 2021-10-20
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05085093. Inclusion in this directory is not an endorsement.